MedPath

MERCK SANTE S.A.S

🇪🇸Spain
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

10

NMPA:7
PHILIPPINES:3

Drug Approvals

Levothyroxine Sodium Tablets

Product Name
优甲乐
Approval Number
国药准字HJ20255001
Approval Date
Jan 13, 2025
NMPA

Levothyroxine Sodium Tablets

Product Name
优甲乐
Approval Number
国药准字HJ20140051
Approval Date
Feb 6, 2024
NMPA

Levothyroxine Sodium Tablets

Product Name
优甲乐
Approval Number
国药准字HJ20140052
Approval Date
Feb 6, 2024
NMPA

Metformin Hydrochloride Tablets

Product Name
盐酸二甲双胍片
Approval Number
国药准字HJ20200040
Approval Date
Sep 30, 2020
NMPA

Metformin Hydrochloride Tablets

Product Name
盐酸二甲双胍片
Approval Number
国药准字HJ20200039
Approval Date
Sep 30, 2020
NMPA

Levothyroxine Sodium Tablets

Product Name
优甲乐
Approval Number
H20140051
Approval Date
Mar 21, 2019
NMPA

Levothyroxine Sodium Tablets

Product Name
优甲乐
Approval Number
H20140052
Approval Date
Mar 21, 2019
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.